中华临床医师杂志(电子版)2023,Vol.17Issue(4) :487-490.DOI:10.3877/cma.j.issn.1674-0785.2023.04.021

肝素结合蛋白在脓毒症中的应用及研究进展

Progress in application of heparin-binding protein in sepsis

蔡荇 郑瑞强
中华临床医师杂志(电子版)2023,Vol.17Issue(4) :487-490.DOI:10.3877/cma.j.issn.1674-0785.2023.04.021

肝素结合蛋白在脓毒症中的应用及研究进展

Progress in application of heparin-binding protein in sepsis

蔡荇 1郑瑞强1
扫码查看

作者信息

  • 1. 225001 江苏扬州,江苏省苏北人民医院重症医学科
  • 折叠

摘要

肝素结合蛋白(HBP)是中性粒细胞受到外界刺激后释放产生的颗粒蛋白,在增加血管内皮通透性、趋化特性及调节炎症反应方面起着至关重要的作用。近年来,随着对HBP研究的逐渐深入,发现HBP可作为诊断脓毒症的早期生物标志物,并证实HBP可预测脓毒症患者疾病严重程度并判断预后情况。本文就HBP在脓毒症中的临床价值进行综述。

Abstract

Heparin-binding protein (HBP) is a kind of granule protein produced by neutrophils in response to external stimuli. It plays a crucial role in increasing vascular permeability, chemotaxis, and regulating inflammatory response In recent years, studies have found that HBP can be used as an early predictor of sepsis. In addition, it has been confirmed that HBP can be used to evaluate the disease severity and prognosis in sepsis patients. This review focuses on the clinical value of HBP in sepsis.

关键词

肝素结合蛋白/脓毒症/生物标志物

引用本文复制引用

出版年

2023
中华临床医师杂志(电子版)
中华医学会

中华临床医师杂志(电子版)

CSTPCD
影响因子:0.99
ISSN:1674-0785
参考文献量57
段落导航相关论文